Wednesday, July 1, 2026

Hair Relaxer and Depo-Provera Lead Concentrated Mid-Year Filing Surge

Tuesday’s federal multidistrict activity was sharply defined by an influx of complex pharmaceutical and personal care product defect claims, led by a 23-case expansion in the Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (MDL 3060). This docket saw significant contributions from Morgan & Morgan PA, which filed ten complaints including Malloy v. L'Oreal USA, Inc., alongside five actions from Wallace Miller. Following closely, the Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation (MDL 3140) added 18 fresh filings, predominantly guided by McSweeney Langevin LLC and MCH Law PLLC as the litigation continues its steady growth ahead of a pending general-causation phase. The third-highest concentration emerged in the Baby Food Products Liability Litigation (MDL 3101) with 16 new complaints, heavily propelled by Dicello Levitt LLP launching eleven suits and Baum Hedlund Aristei Goldman adding two. Rounding out the top five, the Roundup Products Liability Litigation (MDL 2741) and the Covidien Hernia Mesh Products Liability Litigation (No. II) (MDL 3029) recorded six and five new matters respectively, with Clark Chambers PLLC and Doyle APC acting as the primary drivers of volume in these mature medical venues. See the full filing feed and firm-level breakdowns here.

L'Oréal Faces Mounting Benzene Litigation Over CeraVe Acne Treatments

As of late June 2026, parent company L'Oréal is facing mounting public scrutiny and ongoing civil litigation alleging that several of its CeraVe acne treatment products contain dangerously high levels of benzene, a known human carcinogen. The litigation centers on the chemical stability of benzoyl peroxide, with plaintiffs claiming that the active ingredient can degrade into benzene during ordinary storage and shipping conditions. These actions center around six federal class-action lawsuits that were transferred to the Southern District of New York in 2025, where attorneys argue that manufacturers failed to warn consumers about the risks of toxic exposure. While the Food and Drug Administration has previously indicated that the risk from daily use of such products is low, the surge in litigation mirrors previous waves of benzene-related claims targeting dry shampoos and sunscreens.

Arkansas Lawsuit and KIDS Act Escalate Scrutiny of Discord Safety Tools

A recently filed lawsuit by the State of Arkansas has exposed significant design flaws in Discord that allow anonymous adults to bypass parental monitoring tools and prioritize engagement over youth safeguards. Filed on June 22, 2026 by Arkansas Attorney General Tim Griffin, the lawsuit accuses Discord of engineering a platform that "lets children override parental monitoring with a single tap" and hands anonymous adults direct access to minors. The timing coincides with the U.S. House of Representatives passing the Kids Internet and Digital Safety (KIDS) Act on June 29, 2026 by a bipartisan vote of 267-117, a sweeping legislative package imposing stricter accountability standards on technology operators for harmful content and predatory behavior toward minors. The bill now heads to the U.S. Senate.